Aqueous humor is formed by the ciliary processes and flows from the posterior to anterior chamber, exiting through the trabecular and uveoscleral routes. It is continuously formed and drained at a rate of approximately 2.5mL/min. Aqueous outflow occurs through pressure-dependent (trabecular) and pressure-independent (uveoscleral) pathways. Various receptors and drugs that act on these pathways to regulate intraocular pressure are discussed. Common glaucoma medications include prostaglandin analogs, beta-blockers, alpha agonists, cholinergic agonists, and carbonic anhydrase inhibitors.
This document discusses ocular symptoms and their potential causes. It describes symptoms related to vision such as blurred vision, floaters, flashes of light, and diplopia that can indicate issues like retinal detachment, vitreous hemorrhage, or optic neuritis. Symptoms involving the eyelids like lumps, swelling, or drooping may signal problems like entropion or ectropion. Common symptoms of redness, discharge, pain, irritation and burning are discussed in relation to conditions like conjunctivitis, uveitis, glaucoma and dry eyes. The document provides an overview of important symptoms in ophthalmology and their differential diagnoses.
The conjunctiva is a mucous membrane that lines the inner surface of the eyelids and covers the anterior sclera of the eye. It has several functions including lubricating the eye and contributing to immune surveillance. The conjunctiva consists of the palpebral, bulbar, and forniceal conjunctiva. The palpebral conjunctiva lines the inner surface of the eyelids and is subdivided into the marginal, tarsal, and orbital conjunctiva. The bulbar conjunctiva covers the anterior sclera and is separated from it by the episcleral tissue. It consists of the limbal and scleral conjunctiva. The conjunctival fornices are cul
The document discusses various types of drugs used to treat glaucoma, including beta-adrenergic blocking agents, prostaglandins, parasympathomimetic drugs, sympathomimetic drugs, carbonic anhydrase inhibitors, and hyperosmotic agents. It provides details on the mechanism of action, indications, contraindications, and side effects of representative drugs in each class, such as timolol for beta-blockers, latanoprost for prostaglandins, pilocarpine for parasympathomimetics, and glycerol for hyperosmotic agents. The document aims to comprehensively cover the major classes of antiglaucoma medications.
Keratoplasty involves replacing diseased cornea with donor tissue. The main types are penetrating keratoplasty (PK), which replaces the full corneal thickness, and lamellar keratoplasty, which replaces only diseased layers. PK indications include scarring, infections, dystrophies and injuries. It has risks of rejection, infection, and high astigmatism. Newer techniques like deep anterior lamellar keratoplasty (DALK) and Descemet's membrane endothelial keratoplasty (DMEK) replace only diseased layers, reducing risks. Careful donor screening, surgical technique and postoperative management including steroids can reduce complications of keratoplasty.
Bacterial conjunctivitis is a common type of pink eye, caused by bacteria that infect the eye through various sources of contamination. The bacteria can be spread through contact with an infected individual, exposure to contaminated surfaces or through other means such as sinus or ear infections.The most common types of bacteria that causes bacterial conjunctivitis includes Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae and Pseudomonas aeruginosa. Bacterial conjunctivitis usually produces a thick eye discharge or pus and can affect one or both eyes.
conjuctivitis is defined as Inflammation or infection of the outer membrane of the eyeball and the inner eyelid.
It is also known by the name Pink eye.
Conjunctivitis can be considered as allergic, viral or bacterial
viral conjunctivitis is the most common among all and is highly contagious one so the presentation describes the basic overview on viral conjunctivitis
Ophthalmic viscosurgical devices (OVDs) are used in eye surgeries to protect tissues and maintain spaces. Common OVDs include sodium hyaluronate, chondroitin sulfate, and hydroxypropyl methylcellulose. OVDs can be classified as cohesive, dispersive, or viscoadaptive based on their rheological properties such as viscosity and elasticity. Cohesive OVDs are highly viscous and stick together, while dispersive OVDs coat tissues well but are less viscous. OVDs are used in cataract surgery for tasks like protecting the endothelium, maintaining the anterior chamber, and implanting IOLs. Complications can include increased intraocular
Aqueous humor is formed by the ciliary processes and flows from the posterior to anterior chamber, exiting through the trabecular and uveoscleral routes. It is continuously formed and drained at a rate of approximately 2.5mL/min. Aqueous outflow occurs through pressure-dependent (trabecular) and pressure-independent (uveoscleral) pathways. Various receptors and drugs that act on these pathways to regulate intraocular pressure are discussed. Common glaucoma medications include prostaglandin analogs, beta-blockers, alpha agonists, cholinergic agonists, and carbonic anhydrase inhibitors.
This document discusses ocular symptoms and their potential causes. It describes symptoms related to vision such as blurred vision, floaters, flashes of light, and diplopia that can indicate issues like retinal detachment, vitreous hemorrhage, or optic neuritis. Symptoms involving the eyelids like lumps, swelling, or drooping may signal problems like entropion or ectropion. Common symptoms of redness, discharge, pain, irritation and burning are discussed in relation to conditions like conjunctivitis, uveitis, glaucoma and dry eyes. The document provides an overview of important symptoms in ophthalmology and their differential diagnoses.
The conjunctiva is a mucous membrane that lines the inner surface of the eyelids and covers the anterior sclera of the eye. It has several functions including lubricating the eye and contributing to immune surveillance. The conjunctiva consists of the palpebral, bulbar, and forniceal conjunctiva. The palpebral conjunctiva lines the inner surface of the eyelids and is subdivided into the marginal, tarsal, and orbital conjunctiva. The bulbar conjunctiva covers the anterior sclera and is separated from it by the episcleral tissue. It consists of the limbal and scleral conjunctiva. The conjunctival fornices are cul
The document discusses various types of drugs used to treat glaucoma, including beta-adrenergic blocking agents, prostaglandins, parasympathomimetic drugs, sympathomimetic drugs, carbonic anhydrase inhibitors, and hyperosmotic agents. It provides details on the mechanism of action, indications, contraindications, and side effects of representative drugs in each class, such as timolol for beta-blockers, latanoprost for prostaglandins, pilocarpine for parasympathomimetics, and glycerol for hyperosmotic agents. The document aims to comprehensively cover the major classes of antiglaucoma medications.
Keratoplasty involves replacing diseased cornea with donor tissue. The main types are penetrating keratoplasty (PK), which replaces the full corneal thickness, and lamellar keratoplasty, which replaces only diseased layers. PK indications include scarring, infections, dystrophies and injuries. It has risks of rejection, infection, and high astigmatism. Newer techniques like deep anterior lamellar keratoplasty (DALK) and Descemet's membrane endothelial keratoplasty (DMEK) replace only diseased layers, reducing risks. Careful donor screening, surgical technique and postoperative management including steroids can reduce complications of keratoplasty.
Bacterial conjunctivitis is a common type of pink eye, caused by bacteria that infect the eye through various sources of contamination. The bacteria can be spread through contact with an infected individual, exposure to contaminated surfaces or through other means such as sinus or ear infections.The most common types of bacteria that causes bacterial conjunctivitis includes Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae and Pseudomonas aeruginosa. Bacterial conjunctivitis usually produces a thick eye discharge or pus and can affect one or both eyes.
conjuctivitis is defined as Inflammation or infection of the outer membrane of the eyeball and the inner eyelid.
It is also known by the name Pink eye.
Conjunctivitis can be considered as allergic, viral or bacterial
viral conjunctivitis is the most common among all and is highly contagious one so the presentation describes the basic overview on viral conjunctivitis
Ophthalmic viscosurgical devices (OVDs) are used in eye surgeries to protect tissues and maintain spaces. Common OVDs include sodium hyaluronate, chondroitin sulfate, and hydroxypropyl methylcellulose. OVDs can be classified as cohesive, dispersive, or viscoadaptive based on their rheological properties such as viscosity and elasticity. Cohesive OVDs are highly viscous and stick together, while dispersive OVDs coat tissues well but are less viscous. OVDs are used in cataract surgery for tasks like protecting the endothelium, maintaining the anterior chamber, and implanting IOLs. Complications can include increased intraocular
This document summarizes various classes of anti-glaucoma medications, including their mechanisms of action and examples of drugs. It focuses on prostaglandins, describing how latanoprost, bimatoprost, and travoprost work. It also discusses adrenergic medications, carbonic anhydrase inhibitors, cholinergic drugs, and hyperosmotic agents for treating glaucoma. Side effects are provided for each class.
Glaucoma is a group of eye diseases that causes optic nerve damage and vision loss due to increased pressure in the eye (intraocular pressure). The two main types are open-angle glaucoma, which accounts for 90% of cases, and angle-closure glaucoma. Treatment options aim to lower intraocular pressure and prevent further vision loss through eye drop medications, laser treatments, or surgery. Glaucoma can also be caused secondary to other conditions like diabetes or inflammation and may be present from birth in rare cases of congenital glaucoma.
Pinguecula is a common degenerative condition of the conjunctiva that presents as a yellowish white patch near the limbus. It is caused by elastotic degeneration of collagen fibers and deposition of hyaline material in the conjunctiva due to repeated exposure to UV radiation. Pinguecula typically affects males over age 40 who spend significant time outdoors without adequate eye protection. While usually asymptomatic, larger pinguecula can cause irritation, interfere with contact lens wear, or become inflamed. Treatment involves lubrication for irritation and excision only if the pinguecula causes cosmetic or fitting issues.
This presentation summarizes glaucoma, including its etiology, pathophysiology, classification, clinical manifestations, diagnosis, and treatment. Glaucoma refers to a group of eye disorders characterized by optic nerve damage and vision loss due to increased intraocular pressure. It is classified as primary open-angle glaucoma or primary angle-closure glaucoma. Clinical features may include loss of peripheral vision, optic nerve cupping, and visual field defects. Diagnosis involves measuring intraocular pressure, examining the anterior chamber angle and optic disc. Treatment options include non-pharmacological methods as well as topical eye drops to lower pressure such as beta-blockers, alpha-2 agonists, prostaglandins, and
This document presents the case of a 24-year-old female with type 1 diabetes who presented with diminishing vision in both eyes over the past 1-3 months. Her past ocular history included laser treatment for diabetic retinopathy in both eyes the previous December. Her examination revealed proliferative diabetic retinopathy worse in the left eye, with neovascularization, pre-retinal hemorrhage, and subhyaloid hemorrhage. She was diagnosed with high risk proliferative diabetic retinopathy in both eyes and hypertension. Her treatment plan included strict glycemic and blood pressure control, intravitreal injection in the left eye followed by vitrectomy and endolaser, and further testing of the
This document discusses various medical treatments for glaucoma, including topical eye drop medications from different drug classes. It describes the mechanisms of action, administration, efficacy and side effects of prostaglandin analogues, beta blockers, carbonic anhydrase inhibitors, alpha-2 agonists, miotics, osmotic agents, and some combination drug preparations. The document provides detailed information on commonly used glaucoma drugs to help clinicians select appropriate treatment options based on a patient's needs and risk factors.
Glaucoma is a group of eye diseases that damage the optic nerve and causes vision loss and blindness. It is often asymptomatic in the early stages. The main cause is increased pressure within the eye (intraocular pressure) due to impaired fluid drainage from the eye. There are two main types - open angle glaucoma which develops slowly over time and closed angle glaucoma which is a medical emergency with sudden severe eye pain. Treatment aims to reduce intraocular pressure and halt further optic nerve damage.
This document discusses ocular NSAIDs (non-steroidal anti-inflammatory drugs). It begins by outlining the inflammatory response and pharmacologic principles of NSAIDs. It then discusses the classification of NSAIDs and common ophthalmic NSAIDs used. The main indications for ocular NSAIDs are reducing inflammation and pain from conditions like conjunctivitis, corneal injuries, episcleritis, and uveitis. Side effects can include gastric irritation and bleeding risks.
This document summarizes retinal vein occlusion, including branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). It discusses risk factors, pathogenesis, clinical features, evaluation, and treatment approaches. For BRVO, laser photocoagulation and anti-VEGF injections are used to treat macular edema. For CRVO, outcomes depend on initial visual acuity and perfusion status, with neovascularization and macular edema treated similarly to BRVO.
Glaucoma is the second leading cause of blindness worldwide. It involves damage to the optic nerve due to increased intraocular pressure. While pressure within the eye normally ranges from 11-21 mmHg, pressures above 21 are considered high risk for glaucoma. Damage occurs when pressure is not adequately relieved by drainage from the eye. Early detection through screening and treatment can prevent vision loss, but many patients are asymptomatic in early stages when peripheral vision is lost.
Glaucoma is a group of eye diseases that damage the optic nerve and can cause vision loss. It is usually caused by an increase in pressure within the eye due to blocked drainage canals. There are two main types - open angle glaucoma caused by partial blockage and closed angle glaucoma caused by sudden, complete blockage. Treatment aims to lower intraocular pressure through eye drops, oral medication, laser therapy or surgery depending on the severity. Surgical treatment is usually a last resort but is the primary approach for closed angle glaucoma emergencies. Post-operative care involves anti-inflammatory and antibiotic eyedrops.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like anxiety and depression.
CASE PRESENTATION:Corneal stromal dystrophyNilay P
This case presentation discusses Avellino corneal dystrophy in a 45-year-old woman. Examination found multiple white dots in her cornea. Avellino corneal dystrophy is an autosomal dominant condition characterized by granular and lattice deposits in the cornea. Histopathology shows mixed hyaline and amyloid deposits. Initial management included lubricating drops and bandage contact lenses for recurrent erosions. The extensive stromal involvement made deep anterior lamellar keratoplasty difficult, so penetrating keratoplasty was the preferred surgical option.
This document discusses retinal detachment, defining it as the separation of the neurosensory retina from the retinal pigment epithelium, resulting in subretinal fluid accumulation. There are three types of retinal detachment: rhegmatogenous, tractional, and exudative. Rhegmatogenous retinal detachment occurs due to a retinal break, allowing fluid to accumulate under the retina. Tractional retinal detachment is caused by fibrous tissue pulling on the retina. Exudative retinal detachment occurs due to fluid leakage from conditions like inflammation, tumors, or vascular abnormalities, accumulating under the retina without a retinal break.
This document discusses ocular drug delivery systems. It defines ophthalmic preparations as sterile liquid, semi-solid, or solid formulations for application to the eye. The key types are solutions, suspensions, gels, ointments, and inserts. Absorption occurs across the cornea or sclera/conjunctiva. Manufacturing involves active ingredients, vehicles, buffers, and other excipients. Quality control tests for sterility, particles, and assays are described. Packaging and labeling requirements are outlined along with storage and examples of drug classes used to treat eye diseases.
This document discusses glaucoma, including what causes it, types of glaucoma, and treatments. Glaucoma is a disease that causes damage to the eye due to increased pressure from fluid inside the eye. There are two main types: open angle glaucoma, the most common type where fluid drainage is blocked, and angle closure glaucoma where the drain becomes too narrow. Treatments aim to lower pressure by decreasing fluid production or increasing outflow, through drugs like prostaglandin analogues, beta blockers, alpha agonists, and carbonic anhydrase inhibitors. Miotic drugs may also be used but have more side effects. Treatment depends on the type of glaucoma and may involve multiple drug
Drugs used in glaucoma and myasthenia gravisSatyajit Ghosh
1) Drugs used to treat glaucoma work by lowering intraocular pressure through reducing aqueous humor production or increasing outflow. Topical medications include beta blockers, alpha agonists, prostaglandin analogs, carbonic anhydrase inhibitors, and miotics.
2) Angle closure glaucoma requires emergent treatment to rapidly lower pressure including intravenous mannitol or glycerol, oral acetazolamide, and topical pilocarpine and timolol.
3) Myasthenia gravis results from antibodies destroying acetylcholine receptors. Diagnosis involves physical exams, blood tests for antibodies, and electrodiagnostic tests. Treatment includes acetylcholinesterase inhibitors for symptoms and immunos
This document summarizes various classes of anti-glaucoma medications, including their mechanisms of action and examples of drugs. It focuses on prostaglandins, describing how latanoprost, bimatoprost, and travoprost work. It also discusses adrenergic medications, carbonic anhydrase inhibitors, cholinergic drugs, and hyperosmotic agents for treating glaucoma. Side effects are provided for each class.
Glaucoma is a group of eye diseases that causes optic nerve damage and vision loss due to increased pressure in the eye (intraocular pressure). The two main types are open-angle glaucoma, which accounts for 90% of cases, and angle-closure glaucoma. Treatment options aim to lower intraocular pressure and prevent further vision loss through eye drop medications, laser treatments, or surgery. Glaucoma can also be caused secondary to other conditions like diabetes or inflammation and may be present from birth in rare cases of congenital glaucoma.
Pinguecula is a common degenerative condition of the conjunctiva that presents as a yellowish white patch near the limbus. It is caused by elastotic degeneration of collagen fibers and deposition of hyaline material in the conjunctiva due to repeated exposure to UV radiation. Pinguecula typically affects males over age 40 who spend significant time outdoors without adequate eye protection. While usually asymptomatic, larger pinguecula can cause irritation, interfere with contact lens wear, or become inflamed. Treatment involves lubrication for irritation and excision only if the pinguecula causes cosmetic or fitting issues.
This presentation summarizes glaucoma, including its etiology, pathophysiology, classification, clinical manifestations, diagnosis, and treatment. Glaucoma refers to a group of eye disorders characterized by optic nerve damage and vision loss due to increased intraocular pressure. It is classified as primary open-angle glaucoma or primary angle-closure glaucoma. Clinical features may include loss of peripheral vision, optic nerve cupping, and visual field defects. Diagnosis involves measuring intraocular pressure, examining the anterior chamber angle and optic disc. Treatment options include non-pharmacological methods as well as topical eye drops to lower pressure such as beta-blockers, alpha-2 agonists, prostaglandins, and
This document presents the case of a 24-year-old female with type 1 diabetes who presented with diminishing vision in both eyes over the past 1-3 months. Her past ocular history included laser treatment for diabetic retinopathy in both eyes the previous December. Her examination revealed proliferative diabetic retinopathy worse in the left eye, with neovascularization, pre-retinal hemorrhage, and subhyaloid hemorrhage. She was diagnosed with high risk proliferative diabetic retinopathy in both eyes and hypertension. Her treatment plan included strict glycemic and blood pressure control, intravitreal injection in the left eye followed by vitrectomy and endolaser, and further testing of the
This document discusses various medical treatments for glaucoma, including topical eye drop medications from different drug classes. It describes the mechanisms of action, administration, efficacy and side effects of prostaglandin analogues, beta blockers, carbonic anhydrase inhibitors, alpha-2 agonists, miotics, osmotic agents, and some combination drug preparations. The document provides detailed information on commonly used glaucoma drugs to help clinicians select appropriate treatment options based on a patient's needs and risk factors.
Glaucoma is a group of eye diseases that damage the optic nerve and causes vision loss and blindness. It is often asymptomatic in the early stages. The main cause is increased pressure within the eye (intraocular pressure) due to impaired fluid drainage from the eye. There are two main types - open angle glaucoma which develops slowly over time and closed angle glaucoma which is a medical emergency with sudden severe eye pain. Treatment aims to reduce intraocular pressure and halt further optic nerve damage.
This document discusses ocular NSAIDs (non-steroidal anti-inflammatory drugs). It begins by outlining the inflammatory response and pharmacologic principles of NSAIDs. It then discusses the classification of NSAIDs and common ophthalmic NSAIDs used. The main indications for ocular NSAIDs are reducing inflammation and pain from conditions like conjunctivitis, corneal injuries, episcleritis, and uveitis. Side effects can include gastric irritation and bleeding risks.
This document summarizes retinal vein occlusion, including branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). It discusses risk factors, pathogenesis, clinical features, evaluation, and treatment approaches. For BRVO, laser photocoagulation and anti-VEGF injections are used to treat macular edema. For CRVO, outcomes depend on initial visual acuity and perfusion status, with neovascularization and macular edema treated similarly to BRVO.
Glaucoma is the second leading cause of blindness worldwide. It involves damage to the optic nerve due to increased intraocular pressure. While pressure within the eye normally ranges from 11-21 mmHg, pressures above 21 are considered high risk for glaucoma. Damage occurs when pressure is not adequately relieved by drainage from the eye. Early detection through screening and treatment can prevent vision loss, but many patients are asymptomatic in early stages when peripheral vision is lost.
Glaucoma is a group of eye diseases that damage the optic nerve and can cause vision loss. It is usually caused by an increase in pressure within the eye due to blocked drainage canals. There are two main types - open angle glaucoma caused by partial blockage and closed angle glaucoma caused by sudden, complete blockage. Treatment aims to lower intraocular pressure through eye drops, oral medication, laser therapy or surgery depending on the severity. Surgical treatment is usually a last resort but is the primary approach for closed angle glaucoma emergencies. Post-operative care involves anti-inflammatory and antibiotic eyedrops.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like anxiety and depression.
CASE PRESENTATION:Corneal stromal dystrophyNilay P
This case presentation discusses Avellino corneal dystrophy in a 45-year-old woman. Examination found multiple white dots in her cornea. Avellino corneal dystrophy is an autosomal dominant condition characterized by granular and lattice deposits in the cornea. Histopathology shows mixed hyaline and amyloid deposits. Initial management included lubricating drops and bandage contact lenses for recurrent erosions. The extensive stromal involvement made deep anterior lamellar keratoplasty difficult, so penetrating keratoplasty was the preferred surgical option.
This document discusses retinal detachment, defining it as the separation of the neurosensory retina from the retinal pigment epithelium, resulting in subretinal fluid accumulation. There are three types of retinal detachment: rhegmatogenous, tractional, and exudative. Rhegmatogenous retinal detachment occurs due to a retinal break, allowing fluid to accumulate under the retina. Tractional retinal detachment is caused by fibrous tissue pulling on the retina. Exudative retinal detachment occurs due to fluid leakage from conditions like inflammation, tumors, or vascular abnormalities, accumulating under the retina without a retinal break.
This document discusses ocular drug delivery systems. It defines ophthalmic preparations as sterile liquid, semi-solid, or solid formulations for application to the eye. The key types are solutions, suspensions, gels, ointments, and inserts. Absorption occurs across the cornea or sclera/conjunctiva. Manufacturing involves active ingredients, vehicles, buffers, and other excipients. Quality control tests for sterility, particles, and assays are described. Packaging and labeling requirements are outlined along with storage and examples of drug classes used to treat eye diseases.
This document discusses glaucoma, including what causes it, types of glaucoma, and treatments. Glaucoma is a disease that causes damage to the eye due to increased pressure from fluid inside the eye. There are two main types: open angle glaucoma, the most common type where fluid drainage is blocked, and angle closure glaucoma where the drain becomes too narrow. Treatments aim to lower pressure by decreasing fluid production or increasing outflow, through drugs like prostaglandin analogues, beta blockers, alpha agonists, and carbonic anhydrase inhibitors. Miotic drugs may also be used but have more side effects. Treatment depends on the type of glaucoma and may involve multiple drug
Drugs used in glaucoma and myasthenia gravisSatyajit Ghosh
1) Drugs used to treat glaucoma work by lowering intraocular pressure through reducing aqueous humor production or increasing outflow. Topical medications include beta blockers, alpha agonists, prostaglandin analogs, carbonic anhydrase inhibitors, and miotics.
2) Angle closure glaucoma requires emergent treatment to rapidly lower pressure including intravenous mannitol or glycerol, oral acetazolamide, and topical pilocarpine and timolol.
3) Myasthenia gravis results from antibodies destroying acetylcholine receptors. Diagnosis involves physical exams, blood tests for antibodies, and electrodiagnostic tests. Treatment includes acetylcholinesterase inhibitors for symptoms and immunos
GLAUCOMA
,dignosis , types of glaucoma , risk factors oo glaucoma and treatment , the clasis of drugs that use in treatment of glaucoma.
prepared by : Hardi Sdiq
university of sullaimani
collage of pharmacy
Medical treatment of primary open angle glaucomaAdithya Phadnis
The document discusses goals and approaches for treating glaucoma. The primary goal is lowering intraocular pressure to reduce risk of vision loss. Medical approaches include various drug classes that decrease aqueous production or increase outflow, while surgical options are considered when pressure cannot be controlled through medical therapy alone. Follow-up care involves regular exams and testing to monitor pressure and disease stability.
The document discusses various classes of medications used to treat glaucoma by reducing intraocular pressure, including beta-blockers, parasympathomimetics, adrenergic agonists, carbonic anhydrase inhibitors, and prostaglandin analogues. It provides details on the mechanisms of action, common medications, dosages, efficacy and side effects for each class. Beta-blockers such as timolol work by reducing the production of aqueous humor in the eye. Parasympathomimetics like pilocarpine increase outflow of aqueous humor through contraction of the ciliary muscle. Adrenergic agonists decrease aqueous humor production through vasoconstriction and inhibition of enzyme activity. Carbon
Glaucoma is a group of eye diseases that cause damage to the optic nerve and vision loss. Open-angle glaucoma is the most common type, where fluid drainage is impaired but the drainage angle remains open. Elevated intraocular pressure damages the optic nerve over time. Main treatments are eye drop medications that lower pressure by increasing outflow or decreasing fluid production, including prostaglandin analogs, beta-blockers, alpha-2 agonists, and carbonic anhydrase inhibitors. Combination therapy is often used if single drugs do not adequately lower pressure and prevent further vision loss.
Ocular hypotensive drugs are used to reduce intraocular pressure and treat glaucoma. There are several classes of ocular hypotensive drugs: 1) Prostaglandin analogues like latanoprost which increase outflow of aqueous humor, 2) Beta-blockers like timolol which reduce aqueous production, 3) Alpha-2 adrenergic agonists like brimonidine and apraclonidine which decrease aqueous production, 4) Carbonic anhydrase inhibitors like acetazolamide which suppress aqueous humor production, and 5) Cholinergic agonists or miotics like pilocarpine which contract the iris sphincter muscle and ciliary body to facilitate aqueous outflow. Hyper
Glaucoma is a condition where fluid pressure inside the eye rises above healthy levels, which can damage the optic nerve and cause vision loss or blindness if untreated. The two main types are primary open-angle glaucoma, the most common, and closed-angle glaucoma, which is a medical emergency. Treatment aims to lower intraocular pressure through eyedrops, laser treatment, or surgery depending on the type of glaucoma. Regular eye exams are important for early detection and treatment.
This document provides an overview of ocular pharmacology. It discusses ocular anatomy and physiology, pharmacokinetics of ocular drugs, routes of drug administration, therapeutic applications of drugs in ophthalmology including glaucoma treatment, antimicrobial agents, immunomodulatory drugs, and new drug delivery systems. Specific drug classes are explained in depth including prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors, and others for glaucoma treatment. Adverse effects and treatment approaches are also summarized.
MYDRIATIC AND MIOTIC AGENTS AND DRUGS USED IN GLAUCOMA Rishabh Sharma
A brief Pathophysiology Presentation on the topic " MYDRIATIC AND MIOTIC AGENTS AND DRUGS USED IN GLAUCOMA "
Includes Both Open Angle and Closed Angle Glaucoma , their Mechanism Of Onset , Pathophysiology and Treatment ( Drugs Used In Glaucoma )
This document discusses the medical management of glaucoma. It covers principles of diagnosis and assessment, results of clinical trials on glaucoma treatment, pharmacokinetics of topical drugs, educating patients, follow up, and various classes of anti-glaucoma medications including cholinergic stimulants, beta-blockers, alpha-adrenergic receptor antagonists, prostaglandin analogs, and carbonic anhydrase inhibitors. Side effects and administration of these drug classes are also outlined.
Glaucoma is an eye disorder characterized by changes in the optic nerve and loss of vision. It occurs when the intraocular pressure is too high for the optic nerve to function normally. There are several types including primary open-angle glaucoma which is the most common. Risk factors include age over 40, family history, and high eye pressure. Symptoms may include vision loss and visual field defects. Treatment aims to lower eye pressure through eye drops, laser treatment, or surgery depending on the type and severity of glaucoma. Homeopathic medicines can help improve circulation, drainage, and blood supply to slow progression and control symptoms.
Medical Management of Glaucoma (2) (1).pptxAleenaS18
This document discusses the medical management of glaucoma through pharmacological agents. It begins by classifying topical and systemic antiglaucoma medications. It then covers the mechanisms of action, pharmacokinetics, indications, and side effects of various drug classes - including prostaglandin analogues, beta blockers, alpha agonists, and carbonic anhydrase inhibitors. The document emphasizes the importance of balancing efficacy of IOP reduction with minimization of side effects and adherence to treatment.
This document provides an overview of ocular pharmacology, including drug delivery methods to the eyes, factors influencing drug penetration, and common drug classes used for ocular conditions. Topical drops, ointments, and periocular injections are described as local delivery methods. Systemic administration through oral or intravenous routes is also discussed. Common drug classes covered include antibiotics, antivirals, antifungals, glaucoma medications, anti-inflammatories, and diagnostic agents. Side effects and indications for various drugs are highlighted.
This document discusses glaucoma, defining it as an eye disease characterized by loss of retinal ganglion cells and their axons caused by increased intraocular pressure. It is the leading cause of irreversible blindness. There are two main types - open angle glaucoma, the most common type, and angle closure glaucoma. Diagnosis involves measuring intraocular pressure and examining the optic nerve and visual field. Treatment options include eye drop medications, laser treatments, and surgeries like trabeculectomy to improve fluid drainage from the eye. Nursing care focuses on managing pain, allaying fears, and educating patients.
one of my education lecture in ophthalmic hospital about glaucoma patho-physiology and management as illustrated in applied therapeutic 10th edition - clinical pharmacy department
This document discusses drugs used to treat disorders of the eye, ear, nose, and throat (ENT), and skin. It focuses on eye disorders like glaucoma, keratitis, and conjunctivitis. It describes classes of drugs used for the eye, including antimicrobials, anti-inflammatories, glaucoma drugs. For glaucoma, it discusses drug classes that lower intraocular pressure by increasing outflow or decreasing aqueous humor production. The document also briefly discusses ENT disorders like allergic rhinitis and vertigo, as well as various skin disorders and their treatments.
This document summarizes different types of anti-glaucoma drugs. It discusses the classification of these drugs based on their mechanism of action, which includes reducing aqueous production, increasing aqueous outflow, or both. The main classes covered are beta blockers, prostaglandin analogues, parasympathomimetics, sympathomimetics, carbonic anhydrase inhibitors, and hyperosmotics. Specific drugs are provided within each class along with their indications, mechanisms, dosages, and potential side effects. Combination drug therapies are also mentioned. Treatment protocols are outlined for primary open angle glaucoma and acute primary angle-closure glaucoma.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Communicating effectively and consistently with students can help them feel at ease during their learning experience and provide the instructor with a communication trail to track the course's progress. This workshop will take you through constructing an engaging course container to facilitate effective communication.
2. GLAUCOMA
GLAUCOMA IS A DISEASE THAT CAUSES DAMAGE
TO THE EYE.
THIS DISEASE HAPPENS BECAUSE OF INCREASED
PRESSURE IN THE EYE. THE PRESSURE CAUSES
DAMAGE TO THE OPTIC NERVE.
6. WHAT CAUSES GLAUCOMA ?
1. The clear fluid inside the eye is produced by the ciliary body
2. This fluid, known as aqueous humour, flows behind the iris. The
aqueous humour fills the anterior chamber, a space between back
of cornea and front of iris
3. The fluid exists the eye through the structure known as the drainage
angle(Schlemm’s Canal), which is formed inside the anterior the
anterior chamber between iris and cornea.
4. The aqueous filters through this angle and through the sclera or
white part of the eye and then joins with the network of veins
outside the eye
5. Any disruption of this outflow of aqueous – including form certain
eye injuries – can result in an increase in Intra Ocular pressure
(I.O.P.) 6
8. TYPES OF GLAUCOMA
A. Open Angle (Wide angle, Chronic simple)
Glaucoma
B. Angle Closure (Narrow angle, Acute congestive)
Glaucoma
8
9. A. OPEN ANGLE (WIDE ANGLE, CHRONIC
SIMPLE) GLAUCOMA
• It is the most common type.
• The drain structure in the eye – it is called
trabecular meshwork – looks normal, but the
fluid dosen’t flow out like it should
9
10. B. ANGLE CLOSURE (NARROW ANGLE, ACUTE
CONGESTIVE) GLAUCOMA
• It is less common type
• Eye doesn't drain right because the drain
space between iris and cornea become too
narrow
• This can cause a sudden buildup of pressure
in our eye
10
14. ALPHA ADRENERGIC AGONIST
Adrenergic Alpha 1:- vasoconstriction of ciliary muscles
Adrenergic Alpha 2:- Reduce action of ciliary epithelium
activity
Examples : Dipivefrine, Apraclonidine, Brimonidine.
Dipivefrine :- It is a prodrug of ADR; penetrated cornea and
is hydrolyzed by the esterase present there into ADR which
lowers IOT by augmenting uveoscleral outflow.
Apraclonidine :- it decreases aqueous production by
primary alpha 2 and subsidiary alpha 1 action on ciliary
body
Brimonidine :- it is more Alpha 2 selective and more lipofilic
than Apraclonidine. It lowers I.O.T. by reducing aqueous
production and by increasing Uveosclereal flow
14
16. BETA ADRENERGIC BLOCKERS
Beta 2 adrenoreceptors located on ciliary epithelium enhance
aqueous secretion by a increased cAMP and they are blocked by
Timolol / Betaxolol.
Beta blockers reduce the I.O.P by blockade of sympathetic nerve
ending in the ciliary epithelium causing a fall in aqueous humor
production
Timolol :- it is the prototype of ocular beta blockers it is non
selective (β1 + β2)
Betaxolol :- it is a β1 selective blocker offering the advantage of
less bronchopulmonary and probably lee cardiac central and
metabolic side effects. However it is less efficious in lowering I.O.T.
than timolol because, ocular beta receptors are predominantly of
the β2 subtype.
Most opthmalogist prefer to start with betaxolol and change over
to timolol if there is insufficient control or local intolerance to
betaxolol 16
17. CONTINUED
Side effects are
1. Ocular side effect
Stinging(smoke stinging/burning sensation),
redness, dryness of eye, corneal
hypoesthesia(decrease in sensation), blur
vision.
2. Systemic side effect
Bronchospasm, bradycardia ( decrease heart
rate)
17
18. PROSTAGLANDIN ANALOGUE
It act by increasing Uveoscleral outflow, possibly by
increasing permeability of tissues in ciliary muscles or by
an action on episcleral vessels(clear layer on top of the
white part of eye, outside which conjunctiva is present.
Example : Latanoprost, Travoprost, Bimatoprost.
Latanoprost
It is the 1st choice drug for open angle
glaucoma because of
• Good Efficacy (maximum response of drug)
• Once daily Application
• Absence of systemic complication
Bimatoprost
It is equally effective as Latanoprost how ever
it has more side effects
18
20. CARBONIC ANHYDRASE INHIBITORS
MOA
It work by inhibiting carbonic anhydrase
(isoenzyme II), which is found in ciliary body
epithelium. This reduces the formation of
bicarbonate ions, which reduces fluid transport,
reducing fluid I.O.P
Example Acetazolamide, Dorzolamide
Acetazolamide
It is given Orally
Dorzolamide
It is given Topically (external application of the
drug on the surface i.e. skin or mucous
membrane of eye for localized action) 20
21. MIOTICS
These reduce eye pressure by increasing the
drainage of intraocular fluid through the trabecular
meshwork i.e by increasing ciliary muscle tone
These drugs especially Pilocarpine previously were
the standard antiglaucoma drug
However, because of several drawbacks, they are
used only as THE LAST OPTION.
21
23. 23
Start monotherapy with Latanoprost / another PG Analogue / Topical beta blocker
If target I.O.T. is not attained,
Either change over to the alternative drug or use both above concurrently (at the same time) .
When there are contraindication to PG analogues and/or beta blockers or to
supplement their action
Brimonidine / Dorzolamide (occasionally Dipivefrine) are used
Topical miotics and Acetazolamide are added (used as the last Option)
24. ANGLE CLOSURE
24
Vigorous therapy employing several measures to reduce I.O.T.
Hypertonic mannitol
Acetazolamide
Miotic
Tropical beta blockers
Apraclonidine 1% (/Latanoprost 0.005%)
NOTE
These drugs are used only to terminate the attack of angle closure glaucoma
Definitive treatment is surgical or laser peripheral iridotomy (standard first-line
treatment)
These may be treated with these drugs for long periods, but often surgery or laser
therapy is ultimately required.